These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18347155)

  • 1. Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice.
    Takei Y; Saga Y; Mizukami H; Takayama T; Ohwada M; Ozawa K; Suzuki M
    Mol Cancer Ther; 2008 Mar; 7(3):704-11. PubMed ID: 18347155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of peritoneal dissemination of ovarian cancer by tyrosine kinase receptor inhibitor SU6668 (TSU-68).
    Machida S; Saga Y; Takei Y; Mizuno I; Takayama T; Kohno T; Konno R; Ohwada M; Suzuki M
    Int J Cancer; 2005 Mar; 114(2):224-9. PubMed ID: 15551349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer.
    Kohno T; Mizukami H; Suzuki M; Saga Y; Takei Y; Shimpo M; Matsushita T; Okada T; Hanazono Y; Kume A; Sato I; Ozawa K
    Cancer Res; 2003 Aug; 63(16):5091-4. PubMed ID: 12941839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PTEN increases sensitivity to SN-38, an active metabolite of the topoisomerase I inhibitor irinotecan, in ovarian cancer cells.
    Saga Y; Mizukami H; Suzuki M; Kohno T; Urabe M; Ozawa K; Sato I
    Clin Cancer Res; 2002 May; 8(5):1248-52. PubMed ID: 12006545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exogenous PTEN enhances apoptosis in pancreas cancer cell line ASPC-1 induced by hypoxia].
    Li JJ; Li HY; Chen YZ; Li G; Xin Y
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):345-8. PubMed ID: 17044997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of cell migration in ovarian cancer cells mediated by PTEN overexpression.
    Saga Y; Mizukami H; Takei Y; Ozawa K; Suzuki M
    Int J Oncol; 2003 Oct; 23(4):1109-13. PubMed ID: 12963992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells.
    Tian T; Nan KJ; Wang SH; Liang X; Lu CX; Guo H; Wang WJ; Ruan ZP
    Carcinogenesis; 2010 Jul; 31(7):1211-9. PubMed ID: 20430845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene.
    Wu H; Wang S; Weng D; Xing H; Song X; Zhu T; Xia X; Weng Y; Xu G; Meng L; Zhou J; Ma D
    Cancer Lett; 2008 Nov; 271(2):205-14. PubMed ID: 18662848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.
    Byrne AT; Ross L; Holash J; Nakanishi M; Hu L; Hofmann JI; Yancopoulos GD; Jaffe RB
    Clin Cancer Res; 2003 Nov; 9(15):5721-8. PubMed ID: 14654557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.
    Jiang JH; Lv QY; Yi YX; Liao J; Wang XW; Zhang W
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6260-6267. PubMed ID: 30338796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.
    Hasumi Y; Mizukami H; Urabe M; Kohno T; Takeuchi K; Kume A; Momoeda M; Yoshikawa H; Tsuruo T; Shibuya M; Taketani Y; Ozawa K
    Cancer Res; 2002 Apr; 62(7):2019-23. PubMed ID: 11929819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of ovarian cancer by muscle-mediated expression of soluble VEGFR-1/Flt-1 using adeno-associated virus serotype 1-derived vector.
    Takei Y; Mizukami H; Saga Y; Yoshimura I; Hasumi Y; Takayama T; Kohno T; Matsushita T; Okada T; Kume A; Suzuki M; Ozawa K
    Int J Cancer; 2007 Jan; 120(2):278-84. PubMed ID: 17066424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
    Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
    Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Int J Oncol; 2015 Dec; 47(6):2057-63. PubMed ID: 26460696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells.
    Liby TA; Spyropoulos P; Buff Lindner H; Eldridge J; Beeson C; Hsu T; Muise-Helmericks RC
    Int J Cancer; 2012 Feb; 130(3):532-43. PubMed ID: 21351097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adenovirus-mediated overexpression of PTEN and KRT10 improves cisplatin resistance of ovarian cancer in vitro and in vivo.
    Wu H; Wang K; Liu W; Hao Q
    Genet Mol Res; 2015 Jun; 14(2):6591-7. PubMed ID: 26125866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression levels of PTEN, HIF-1α, and VEGF as prognostic factors in ovarian cancer.
    Shen W; Li HL; Liu L; Cheng JX
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2596-2603. PubMed ID: 28678326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.